In aggressive prostate and breast cancer cells, FABP5 knockdown repressed the expression of genes involved in lipolysis, including HSL and MAGL, as well as that of genes involved in de novo FA synthesis, such as ELOVL6 and ACSL1. Here, ELOVL6 is linked to breast carcinoma.